...
首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Formulation and Development of Temperature Sensitive In Situ Gelling System of Desmopressin Acetate for Nasal Drug Delivery
【24h】

Formulation and Development of Temperature Sensitive In Situ Gelling System of Desmopressin Acetate for Nasal Drug Delivery

机译:醋酸去氨加压素温度敏感型原位凝胶系统的研制与开发

获取原文
           

摘要

The present work was aimed for the formulation development of stable temperature sensitive thermoreversible in situ gel of desmopressin acetate by cold method using different ratio of Pluronic F127 and Pluronic F68 as thermoreversible polymer. The 3 2 factorial design was employed using concentration of Pluronic F127 and concentration of Pluronic F68 as independent variables and Viscosity and Mucoadhesive strength were selected as dependent variables. The optimized batch was selected using Design Expert software employing overlay plot with desirability approach. The temperature sensitive thermoreversible in situ gel formulation was evaluated for inflection point, gelation temperature, pH, viscosity, % drug content, gel strength, mucoadhessive strength, nasal toxicity study, ex vivo drug diffusion study, stability study and in-vivo study. The composition of optimized formulation consisted of 1 mg of Desmopressin acetate, 1988.67 mg of Pluronic F127, 305.33 mg of Pluronic F68, 1 mg of Benzylkonium chloride and 10 ml of Purified water showing inflection point (32.5 ° C), gelation temperature (33 ° C), viscosity (789.7 cps), mucoadhesive strength (2759.14 dynes/cm 2 ) and % drug content (99.8 %). Temperature sensitive thermoreversible in situ gel increase the nasal residence time and the drug get released in a sustained and controlled manner thus increased the bioavailability of desmopressin acetate.
机译:本工作旨在通过使用不同比例的Pluronic F127和Pluronic F68作为热可逆聚合物的冷方法,通过冷方法制备稳定的温度敏感的醋酸去氨加压素热可逆原位凝胶制剂。使用Pluronic F127的浓度和Pluronic F68的浓度作为自变量,采用3 2因子设计,并选择粘度和粘膜黏附强度作为因变量。使用Design Expert软件通过采用覆盖图和合意方法来选择优化的批次。对温度敏感的热可逆原位凝胶制剂进行了拐点,凝胶化温度,pH,粘度,%药物含量,凝胶强度,粘膜粘附强度,鼻腔毒性研究,离体药物扩散研究,稳定性研究和体内研究的评估。优化配方的组成包括:1 mg醋酸去氨加压素,1988.67 mg Pluronic F127、305.33 mg Pluronic F68、1 mg苄基氯化铵和10 ml具拐点(32.5°C)的纯净水,胶凝温度(33°C) C),粘度(789.7 cps),粘膜粘附强度(2759.14达因/ cm 2)和%药物含量(99.8%)。对温度敏感的热可逆原位凝胶增加了鼻腔停留时间,药物以持续和受控的方式释放,因此增加了醋酸去氨加压素的生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号